Is Alpa Laboratories the Best Stock in Its Sector? A Look at the Numbers
- September 23, 2026
- Posted by: Harsh Piplani
- Category: Market
Alpa Laboratories CMP Rs 61 (23 Sep 2026). Market cap Rs 128 Cr. ROE 8.06%. P/E 31.43x versus Industry P/E 38.56x.
Quick Answer
Alpa Laboratories is one of the names investors compare when screening the Healthcare sector, built on a 8.06% return on equity and a P/E of 31.43x against an Industry P/E of 38.56x. Whether Alpa Laboratories is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.
Is Alpa Laboratories the best stock in its sector? The stock trades on the NSE at Rs 61 as of 23 September 2026, within its 52-week range of Rs 46.10 to Rs 95.00. Alpa Laboratories Ltd manufactures pharmaceutical formulations, primarily tablets and capsules, for domestic institutional and export customers.
Alpa Laboratories sits in the Healthcare sector, and its 8.06% ROE and 31.43x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P/E benchmark.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About Alpa Laboratories
Alpa Laboratories Ltd manufactures pharmaceutical formulations, primarily tablets and capsules, for domestic institutional and export customers. It manufactures pharmaceutical formulations, primarily tablets and capsules, supplying domestic institutional and export customers from its Madhya Pradesh facility. At a market capitalisation of Rs 128 Cr, it is tracked as part of the Healthcare sector on Univest.
Is Alpa Laboratories the Best Stock in Its Sector?
Alpa Laboratories makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 8.06% ROE with a 31.43x P/E against the sector’s 38.56x Industry P/E. Alpa Laboratories trades below its own book value with an 8.06% ROE that trails the larger pharma formulation and API peers used elsewhere in this series, consistent with its smaller operating scale.
| Metric | Alpa Laboratories |
|---|---|
| CMP (NSE) | Rs 61.36 |
| 52-Week High / Low | Rs 95.00 / Rs 46.10 |
| Market Cap | Rs 128 Cr |
| P/E (TTM) vs Industry P/E | 31.43x vs 38.56x |
| P/B | 0.69 |
| ROE | 8.06% |
| EPS (TTM) | Rs 1.93 |
| Dividend Yield | 0.00% |
| Debt to Equity | 0.01 |
Compare Alpa Laboratories Against Other Healthcare Sector Stocks
How Alpa Laboratories Compares Against Its Healthcare Sector Peers
The table below sets Alpa Laboratories against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| Alpa Laboratories | 128 | 31.43 | 8.06% | 0.01 |
| Bajaj Healthcare | 1,125 | 63.76 | 8.81% | 0.47 |
| Anuh Pharma | 942 | 21.32 | 11.65% | 0.00 |
| Peer average (2 companies) | – | 42.54 | 10.23% | 0.23 |
Against this peer set, Alpa Laboratories’s 8.06% ROE is below the 10.23% peer average, and its P/E of 31.43x runs below the peer average of 42.54x. Alpa Laboratories trades below its own book value with an 8.06% ROE that trails the larger pharma formulation and API peers used elsewhere in this series, consistent with its smaller operating scale.
What Makes Alpa Laboratories Worth Watching in Healthcare
- Trading below book value: A P/B of 0.69 means the stock trades below its stated book value.
- Near debt free: A debt to equity ratio of 0.01 gives Alpa Laboratories significant balance sheet flexibility.
- Below Industry P/E: A 31.43x P/E against a 38.56x Industry P/E is a modest discount relative to the Healthcare sector.
Alpa Laboratories Valuation: Is It Justified?
Alpa Laboratories trades below its own book value with an 8.06% ROE that trails the larger pharma formulation and API peers used elsewhere in this series, consistent with its smaller operating scale. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Allied Blenders and Distillers the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track Alpa Laboratories and other Healthcare sector stocks.
How to Track Alpa Laboratories Before You Invest
Before deciding whether Alpa Laboratories deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.
- Open the Univest Screener and search for Alpa Laboratories to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
- Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
Alpa Laboratories earns a place in the best stock in its sector conversation on the strength of a 8.06% ROE and a P/E of 31.43x against a 38.56x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is Alpa Laboratories the best stock in its sector?
Ans. Alpa Laboratories has a 8.06% ROE and trades at 31.43x P/E against a 38.56x Industry P/E, and compares below the peer average ROE of 10.23% in this article’s named comparison, so the answer depends on what an investor is prioritising.
What is the current share price of Alpa Laboratories?
Ans. Alpa Laboratories was trading at Rs 61.36 on the NSE as of 23 September 2026, within its 52-week range of Rs 46.10 to Rs 95.00.
What sector does Alpa Laboratories belong to?
Ans. Alpa Laboratories is classified under the Healthcare sector on Univest.
How does Alpa Laboratories compare to its sector peers on P/E?
Ans. Alpa Laboratories’s P/E of 31.43x is below the 42.54x average of the 2 named peers compared in this article.
What is Alpa Laboratories’s return on equity?
Ans. Alpa Laboratories reported a return on equity of 8.06%, which is below the 10.23% average of its named peers in this comparison.
Should I invest in Alpa Laboratories based on its sector position?
Ans. Alpa Laboratories’s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.
